5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | NEUTRAL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 8.71▲ | 8.67▲ | 8.66▲ | 8.64▲ | 8.70▲ |
MA10 | 8.69▲ | 8.64▲ | 8.65▲ | 8.61▲ | 9.48▼ |
MA20 | 8.67▲ | 8.65▲ | 8.65▲ | 8.71▲ | 10.53▼ |
MA50 | 8.64▲ | 8.65▲ | 8.61▲ | 9.74▼ | 12.47▼ |
MA100 | 8.65▲ | 8.61▲ | 8.67▲ | 10.68▼ | 32.42▼ |
MA200 | 8.65▲ | 8.69▲ | 8.74▼ | 12.00▼ | 43.32▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.006▲ | 0.007▲ | 0.004▲ | 0.077▲ | 0.122▲ |
RSI | 76.090▲ | 62.796▲ | 58.952▲ | 42.458▼ | 30.048▼ |
STOCH | 92.075▲ | 63.358 | 41.228 | 46.989 | 4.983▼ |
WILL %R | -5.000▲ | -18.421▲ | -18.421▲ | -54.545 | -92.443▼ |
CCI | 126.812▲ | 156.461▲ | 141.513▲ | 9.622 | -65.436 |
Thursday, October 16, 2025 07:49 AM
Detailed price information for Verrica Pharmaceuticals Inc (VRCA-Q) from The Globe and Mail including charting and trades.
|
Monday, October 13, 2025 03:00 AM
Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) announced that it will present new data on its investigational oncolytic peptide therapy, VP-315, for the treatment of basal cell carcinoma ...
|
Sunday, October 12, 2025 06:00 AM
PHILADELPHIA, PA — Context Therapeutics Inc. (Nasdaq: CNTX) announced that it will present new clinical and preclinical data at the Society for Immunotherapy of Cancer’s (SITC) 40th Annual Meeting, ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
20/10/25 | 8.67 | 8.765 | 8.575 | 8.72 | 643,641 |
17/10/25 | 8.58 | 8.735 | 8.58 | 8.63 | 615,422 |
16/10/25 | 8.665 | 8.73 | 8.555 | 8.61 | 709,733 |
15/10/25 | 8.626 | 8.81 | 8.61 | 8.64 | 830,380 |
14/10/25 | 8.54 | 8.6801 | 8.50 | 8.61 | 884,367 |
13/10/25 | 8.43 | 8.645 | 8.42 | 8.64 | 1,127,883 |
10/10/25 | 8.60 | 8.62 | 8.42 | 8.42 | 982,951 |
09/10/25 | 8.675 | 8.685 | 8.56 | 8.59 | 586,204 |
08/10/25 | 8.62 | 8.64 | 8.48 | 8.63 | 698,321 |
07/10/25 | 8.585 | 8.63 | 8.445 | 8.58 | 998,267 |
|
|
||||
|
|
||||
|
|